TAT-327 is the conjugation of Eps8-derived peptide 327 (Cat# AS-65675) to the TAT sequence resulted in potent antitumor effect by inhibiting the Eps8/EGFR interaction and selective insertion into cancer cell membranes.
Usually ships within 24 hours.